CD68 and breast cancer: The Kaplan-Meier survival curve showed that greater expression of S100A4 and CD68 was predictive of reduced relapse-free survival of patients with breast cancer (figure 3D), and of reduced overall survival of patients with ovarian or lung cancer after chemotherapy (figure 3E, F).